We hope everyone had an enjoyable and safe December, with happy, relaxing holidays. As 2011 approaches, a plethora of finance gurus have begun issuing their tips and recommendations for the new year. This morning alone, we’ve seen positive articles come out from Seeking Alpha (“4 Reasons Why Stocks Will Rally Again in 2011?), The Street and CNBC’s Jim Cramer, who expects the DOW to increase 16% next year, and Bloomberg News’ John Dorfman (“…Top 10 List for 2011?), among many others. But while many are optimistic over the economy for 2011, others are taking a more cautious approach, as suggested by this morning’s Business Insider article, “5 Stocks Due for a Pullback.” Netflix, Amazon, and stocks tied to the health of the Chinese market (e.g., Baidu) are addressed.

Today we issued an updated, 44-page  Executive Informational Overview® (EIO®) on BELLUS Health Inc. (BLU-TSX). BELLUS, up more than 100% this morning after announcing the start of a Phase III trial for KIACTA yesterday, is a global health company focused on the research and development of innovative health solutions for critical, unmet medical needs. The Company’s pharmaceutical pipeline targets disorders for which there are no known cures.

News from our coverage universe this week includes Johnson & Johnson’s bid to buy Crucell for $2.3 billion, the distribution of two of Bioniche’s cattle reproduction products in Australia, the latest advances in CEL-SCI’s Multikine^® manufacturing and laboratory operations, and the upcoming release of Peregrine’s 2Q2011 financial results.

After the close of business today, we released a new report on Authentidate Holding Corp. (ADAT-NASDAQ). We first initiated coverage on Authentidate in March 2009 and have watched the company expand greatly since then. Its flagship product is Inscrybe^® Healthcare, which provides a means for healthcare organizations and other enterprises to increase revenues, improve productivity, enhance patient care, and reduce costs by eliminating paper and manual work steps while enhancing regulatory compliance. During the past year, Authentidate has announced 11 new projects for Inscrybe^® Healthcare, which include sales to home medical equipment companies, home healthcare service agencies, and respiratory products and service institutions.